NO901461D0 - Antistoffer mot retinoblastomgenprodukt og anvendelse derav. - Google Patents

Antistoffer mot retinoblastomgenprodukt og anvendelse derav.

Info

Publication number
NO901461D0
NO901461D0 NO901461A NO901461A NO901461D0 NO 901461 D0 NO901461 D0 NO 901461D0 NO 901461 A NO901461 A NO 901461A NO 901461 A NO901461 A NO 901461A NO 901461 D0 NO901461 D0 NO 901461D0
Authority
NO
Norway
Prior art keywords
retinoblastom
product
antibodies against
determining
retinoblastoma
Prior art date
Application number
NO901461A
Other languages
English (en)
Other versions
NO179328B (no
NO901461L (no
NO179328C (no
Inventor
Yuen Kai Fung
Ang Anne T
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of NO901461D0 publication Critical patent/NO901461D0/no
Publication of NO901461L publication Critical patent/NO901461L/no
Publication of NO179328B publication Critical patent/NO179328B/no
Publication of NO179328C publication Critical patent/NO179328C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4736—Retinoblastoma protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cosmetics (AREA)
NO901461A 1989-03-31 1990-03-30 Antistoffer mot retinoblastom-genprodukt, anvedelse derav samt murint hybridom NO179328C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33208289A 1989-03-31 1989-03-31

Publications (4)

Publication Number Publication Date
NO901461D0 true NO901461D0 (no) 1990-03-30
NO901461L NO901461L (no) 1990-10-01
NO179328B NO179328B (no) 1996-06-10
NO179328C NO179328C (no) 1996-09-18

Family

ID=23296661

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901461A NO179328C (no) 1989-03-31 1990-03-30 Antistoffer mot retinoblastom-genprodukt, anvedelse derav samt murint hybridom

Country Status (15)

Country Link
EP (1) EP0390530B1 (no)
JP (1) JPH04193900A (no)
KR (1) KR0175658B1 (no)
CN (1) CN1046759A (no)
AT (1) ATE122723T1 (no)
AU (1) AU638238B2 (no)
CA (1) CA2013544C (no)
DE (1) DE69019410T2 (no)
FI (1) FI901618A0 (no)
IE (1) IE63277B1 (no)
IL (1) IL93941A (no)
NO (1) NO179328C (no)
NZ (1) NZ233147A (no)
PT (1) PT93619A (no)
ZA (1) ZA902425B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994001467A1 (en) * 1992-07-14 1994-01-20 Canji, Inc. Characterization of a novel anti-p110rb monoclonal antibody
US5545527A (en) 1994-07-08 1996-08-13 Visible Genetics Inc. Method for testing for mutations in DNA from a patient sample
US5550020A (en) * 1994-07-08 1996-08-27 Visible Genetics Inc. Method, reagents and kit for diagnosis and targeted screening for retinoblastoma
EP2014772A3 (en) * 1996-04-05 2009-05-27 Antonio Giordano Method for the diagnosis and prognosis of cancer
US5840506A (en) * 1996-06-05 1998-11-24 Thomas Jefferson University Methods for the diagnosis and prognosis of cancer
EP2181704B1 (en) 2002-12-30 2015-05-06 Angiotech International Ag Drug delivery from rapid gelling polymer composition
TW200741009A (en) 2005-07-01 2007-11-01 Oncotherapy Science Inc Methods of modulating SMYD3 for treatment of cancer
CN102053150B (zh) * 2009-10-30 2013-07-17 上海交通大学医学院附属瑞金医院 一种人成骨肉瘤干细胞相关抗原标记物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3163090B2 (ja) * 1988-01-21 2001-05-08 マサチューセッツ アイ アンド イヤー インファーマリー 網膜芽腫診断剤

Also Published As

Publication number Publication date
ATE122723T1 (de) 1995-06-15
JPH04193900A (ja) 1992-07-13
PT93619A (pt) 1990-11-20
KR900013987A (ko) 1990-10-22
AU5246190A (en) 1990-10-04
AU638238B2 (en) 1993-06-24
EP0390530B1 (en) 1995-05-17
FI901618A0 (fi) 1990-03-30
KR0175658B1 (ko) 1999-03-20
NO179328B (no) 1996-06-10
NZ233147A (en) 1993-04-28
IL93941A0 (en) 1990-12-23
NO901461L (no) 1990-10-01
ZA902425B (en) 1991-01-30
IL93941A (en) 1995-03-30
DE69019410T2 (de) 1995-10-05
CA2013544C (en) 2001-02-06
NO179328C (no) 1996-09-18
CN1046759A (zh) 1990-11-07
IE901179L (en) 1990-09-30
IE63277B1 (en) 1995-04-05
CA2013544A1 (en) 1990-09-30
DE69019410D1 (de) 1995-06-22
EP0390530A1 (en) 1990-10-03

Similar Documents

Publication Publication Date Title
GB9824632D0 (en) Biological compounds
DE3882847D1 (de) Verfahren zur unmittelbaren bestimmung physikalischer eigenschaften von kohlenwasserstoffprodukten.
FI885543A0 (fi) Dna-segment, polypeptider och anti-kroppar anslutande till human vaevnadsfaktor.
DE69223284D1 (de) Methoden zur Bestimmung von Krebsmetastasen mittels Nukleinsäuren-Amplifikation
CA2082382A1 (en) Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
ATE169640T1 (de) Arzneimittelzusammensetzung zur behandlung oder vorbeugung maligner tumore
DE3881715D1 (de) Produkt fuer schleifzwecke.
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
AU7079396A (en) Anti-galalpha(1,3)gal antibody binding peptides
DE68925226D1 (de) Monoklonale Antikörper
NO901461D0 (no) Antistoffer mot retinoblastomgenprodukt og anvendelse derav.
DE3874387D1 (de) Immunologische methoden und materialien zur bestimmung von tumor assoziierten antigenen.
CA2185112A1 (en) Humanized monoclonal antibodies against human interleukin-4
HK1021229A1 (en) A in vitro method of determining the presence of aprotein in an isolated biological sample.
EP0921194A3 (en) TRAILLK-2: a member of the TNF ligand family
DE69823660D1 (de) Methode zur identifizierung von tumorantigenen mit autoantikörpern in serum
EP0919620A3 (en) TRAILLK-3: a member of the TNF ligand family
DE3781745D1 (de) Antikoerper zur verwendung fuer die bestimmung von menschlichem glycoalbumin.
DE59004279D1 (de) Verfahren zur C-terminalen Modifizierung von Proteinen.
DE68907377D1 (de) Agens und geraet zur bestimmung von antigenen oder antikoerpern.
DE58907208D1 (de) Verfahren zur Bestimmung von Antikörpern.
Thaxton HUMAN ALPHA 1-ACID GLYCOPROTEIN: A STUDY OF GENETIC VARIATION.
ATE103073T1 (de) Verfahren zur bestimmung von antikoerpern.
ZA958038B (en) Isolated truncated nucleic acid molecules which code for gage tumor rejection antigen the tumor rejection antigen and uses thereof
ATE90606T1 (de) Produkt fuer schleifzwecke.